| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | NRIP1 BCAS3 NACA DACT2 APBB3 MEF2A STAT5A BRD8 PER3 BSN MED13 RB1 PCLO TACC2 RUNX1 RUNX3 BHLHE40 TAF3 TLE1 TLE4 EHMT1 CNOT1 LRIF1 | 3.76e-06 | 753 | 207 | 23 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription corepressor binding | 3.29e-05 | 59 | 207 | 6 | GO:0001222 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DAB2IP BCL9L NRIP1 ABL1 GATAD2A NACA GON4L KMT2E GFI1 BRD8 TJP2 SLA2 MED13 TNS3 SHANK1 ANK3 RB1 DTL MED13L CBFA2T3 NCOA5 TIRAP TLE1 PPP4R2 TLE4 ZBED1 | 1.76e-04 | 1160 | 207 | 26 | GO:0030674 |
| GeneOntologyBiologicalProcess | microtubule-based process | ABL1 KIF26A CUL9 NCKAP5 CLASP2 DCX FSIP2 ATXN7 PKD1 MLH1 KIF14 MAP7D2 BSN WDR62 DNAH3 CDC42BPA KIF27 POC1A ANK3 BAG3 CAMSAP3 FSD1 TACC2 SPECC1L CDCA8 CCDC88C MEGF8 CEP70 LSM14A ESPL1 | 1.94e-07 | 1058 | 204 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ABL1 CUL9 NCKAP5 CLASP2 DCX FSIP2 ATXN7 PKD1 MLH1 KIF14 MAP7D2 WDR62 CDC42BPA POC1A ANK3 CAMSAP3 FSD1 TACC2 SPECC1L CDCA8 CCDC88C CEP70 LSM14A ESPL1 | 2.09e-07 | 720 | 204 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 3.97e-06 | 66 | 204 | 7 | GO:0007019 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DAB2IP NRIP1 KLF12 GATAD2A ZNF174 NACA APBB3 MEF2A ZEB2 GFI1 GATAD2B PER3 SLA2 DLX4 TRAF7 RB1 RUNX1 CBFA2T3 RUNX3 GTF2IRD1 BHLHE40 NCOA5 TAF3 TLE1 TLE4 EHMT1 CNOT1 | 5.58e-06 | 1053 | 204 | 27 | GO:0000122 |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 2.79e-05 | 60 | 204 | 6 | GO:0021587 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 3.47e-05 | 38 | 204 | 5 | GO:0007026 | |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP FILIP1 ABL1 ABL2 MYCBP2 DGKB CLASP2 DCX TJP2 BSN SHANK1 WHRN CACNA1A ANK3 PODXL PPFIA4 PCLO SH3GL2 CAMSAP3 SPECC1L ROBO2 TNS1 PDZRN3 MUSK | 3.66e-05 | 974 | 204 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | ABL1 CLASP2 ATXN7 PKD1 WDR62 POC1A CAMSAP3 FSD1 TACC2 SPECC1L CCDC88C CEP70 | 3.73e-05 | 293 | 204 | 12 | GO:0032886 |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 4.05e-05 | 64 | 204 | 6 | GO:0021575 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | ABL1 ABL2 GATAD2A CLASP2 ZEB2 STAT5A PKD1 HS3ST3B1 CPLANE1 PLXNA1 FAT4 PODXL CAMSAP3 SPECC1L RUNX1 RUNX3 ADAMTS12 MEGF8 | 4.62e-05 | 619 | 204 | 18 | GO:0002009 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP FILIP1 ABL1 ABL2 MYCBP2 DGKB CLASP2 DCX BSN SHANK1 CACNA1A ANK3 PODXL PPFIA4 PCLO SH3GL2 ROBO2 PDZRN3 MUSK | 5.33e-05 | 685 | 204 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-2 production | 5.69e-05 | 42 | 204 | 5 | GO:0032743 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 5.69e-05 | 42 | 204 | 5 | GO:0031114 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 6.64e-05 | 176 | 204 | 9 | GO:0070507 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP SETX ABL1 ABL2 MYCBP2 KIF26A CLASP2 DCX MEF2A ZEB2 GFI1 ATXN2 CXCL6 PLXNA1 SHANK1 WHRN CACNA1A FAT4 NYAP2 ANK3 RB1 SH3GL2 CAMSAP3 RUNX3 ARSB MEGF8 ROBO2 MUSK | 7.02e-05 | 1285 | 204 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | cerebellum development | 7.43e-05 | 139 | 204 | 8 | GO:0021549 | |
| GeneOntologyBiologicalProcess | spindle organization | 8.21e-05 | 224 | 204 | 10 | GO:0007051 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.52e-05 | 144 | 204 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 9.93e-05 | 75 | 204 | 6 | GO:0032922 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 9.99e-05 | 25 | 204 | 4 | GO:0021692 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 1.06e-04 | 187 | 204 | 9 | GO:1902850 | |
| GeneOntologyBiologicalProcess | regulation of blood-brain barrier permeability | 1.09e-04 | 10 | 204 | 3 | GO:1905603 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell activation | 1.09e-04 | 10 | 204 | 3 | GO:2001187 | |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP SETX ABL1 ABL2 MYCBP2 KIF26A CLASP2 DCX MEF2A ZEB2 GFI1 ATXN2 CXCL6 PLXNA1 SHANK1 WHRN CACNA1A FAT4 NYAP2 ANK3 RB1 SAMD4B SH3GL2 CAMSAP3 RUNX1 RUNX3 ARSB MEGF8 ROBO2 MUSK | 1.13e-04 | 1463 | 204 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DAB2IP NRIP1 KLF12 GATAD2A CIART ZNF174 NACA APBB3 GON4L MEF2A ZEB2 GFI1 GATAD2B PER3 SLA2 DLX4 TRAF7 RB1 RUNX1 CBFA2T3 RUNX3 GTF2IRD1 BHLHE40 NCOA5 TAF3 TLE1 TLE4 EHMT1 CNOT1 | 1.24e-04 | 1399 | 204 | 29 | GO:0045892 |
| GeneOntologyBiologicalProcess | developmental maturation | DAB2IP PDE3A ABL2 KIF14 SHANK1 CACNA1A FAT4 ANK3 RB1 RUNX1 RUNX3 ADAMTS12 ROBO2 WEE2 | 1.27e-04 | 439 | 204 | 14 | GO:0021700 |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.32e-04 | 151 | 204 | 8 | GO:0007052 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.45e-04 | 153 | 204 | 8 | GO:0022037 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.46e-04 | 51 | 204 | 5 | GO:0031111 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DAB2IP NRIP1 KLF12 GATAD2A CIART ZNF174 NACA APBB3 GON4L MEF2A ZEB2 GFI1 GATAD2B PER3 SLA2 DLX4 TRAF7 RB1 RUNX1 CBFA2T3 RUNX3 GTF2IRD1 BHLHE40 NCOA5 TAF3 TLE1 TLE4 EHMT1 CNOT1 | 1.47e-04 | 1413 | 204 | 29 | GO:1902679 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | ABL1 ABL2 GATAD2A CLASP2 ZEB2 STAT5A PKD1 HS3ST3B1 CPLANE1 PLXNA1 FAT4 PODXL CAMSAP3 SPECC1L RUNX1 RUNX3 ADAMTS12 MEGF8 ROBO2 | 1.74e-04 | 750 | 204 | 19 | GO:0048729 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 2.75e-04 | 168 | 204 | 8 | GO:0031109 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | DAB2IP PDE3A APBB3 CUL9 KMT2E PKD1 MKI67 KIF14 WDR62 TICRR POC1A RB1 DTL CAMSAP3 FSD1 CDCA8 RFWD3 WEE2 CDC25A ESPL1 | 2.86e-04 | 845 | 204 | 20 | GO:0010564 |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 2.90e-04 | 3 | 204 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 3.04e-04 | 33 | 204 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | head development | DAB2IP ABL1 ABL2 KIF26A DCX RTN1 ZEB2 ATXN2 KIF14 CPLANE1 PLXNA1 WDR62 WHRN CACNA1A FAT4 KIF27 SAMD4B TACC2 SPECC1L ARSB ROBO2 | 3.21e-04 | 919 | 204 | 21 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 3.41e-04 | 34 | 204 | 4 | GO:1903055 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DAB2IP SETX ABL1 ABL2 MYCBP2 KIF26A DCX ZEB2 GFI1 CXCL6 PLXNA1 CACNA1A ARSB MEGF8 ROBO2 MUSK | 4.05e-04 | 612 | 204 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell junction maintenance | 4.60e-04 | 65 | 204 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | ABL1 CUL9 CLASP2 KMT2E STAT5A PKD1 MKI67 KIF14 WDR62 TICRR POC1A ANK3 RB1 DTL FSD1 TACC2 CDCA8 RFWD3 WEE2 LSM14A CDC25A ESPL1 | 4.68e-04 | 1014 | 204 | 22 | GO:0000278 |
| GeneOntologyBiologicalProcess | cellular component maintenance | 5.05e-04 | 101 | 204 | 6 | GO:0043954 | |
| GeneOntologyBiologicalProcess | regulation of JUN kinase activity | 5.29e-04 | 67 | 204 | 5 | GO:0043506 | |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 5.76e-04 | 4 | 204 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane tubulation | 5.76e-04 | 4 | 204 | 2 | GO:1903527 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 5.76e-04 | 4 | 204 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 5.76e-04 | 4 | 204 | 2 | GO:1903905 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 5.83e-04 | 39 | 204 | 4 | GO:0021680 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 4 signaling pathway | 6.43e-04 | 40 | 204 | 4 | GO:0034143 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 6.62e-04 | 147 | 204 | 7 | GO:0021987 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 6.67e-04 | 240 | 204 | 9 | GO:0070374 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | DAB2IP PDE3A ABL1 APBB3 CUL9 KMT2E STAT5A BRD8 PTPRC PKD1 MKI67 KIF14 WDR62 TICRR POC1A RB1 DTL CAMSAP3 FSD1 RUNX3 CDCA8 RFWD3 WEE2 CDC25A ESPL1 | 6.80e-04 | 1256 | 204 | 25 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 7.21e-04 | 108 | 204 | 6 | GO:0031110 | |
| GeneOntologyCellularComponent | microtubule organizing center | CLASP2 KMT2E USH2A WDR62 WHRN POC1A PODXL UBR4 DTL CAMSAP3 FSD1 TACC2 SPECC1L CCDC77 SPECC1 RABL6 CCDC88C PPP4R2 CEP70 ESPL1 ZBED1 LRIF1 | 1.22e-04 | 919 | 207 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 2.54e-04 | 13 | 207 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | core-binding factor complex | 2.91e-04 | 3 | 207 | 2 | GO:0016513 | |
| GeneOntologyCellularComponent | USH2 complex | 5.78e-04 | 4 | 207 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | recombination nodule | 5.78e-04 | 4 | 207 | 2 | GO:0005713 | |
| GeneOntologyCellularComponent | nuclear body | NRIP1 SETX ABL1 GATAD2A CIART ZNF174 APBB3 GON4L KMT2E GFI1 GATAD2B MKI67 REXO4 RB1 BHLHE40 VIRMA RFWD3 EHMT1 SRRM2 ZBED1 | 6.75e-04 | 903 | 207 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | centrosome | CLASP2 KMT2E WDR62 POC1A PODXL UBR4 DTL CAMSAP3 FSD1 TACC2 CCDC77 RABL6 CCDC88C PPP4R2 CEP70 ESPL1 ZBED1 LRIF1 | 6.80e-04 | 770 | 207 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L HIVEP2 GATAD2A MEF2A GFI1 GATAD2B STAT5A ATXN7 MGA RB1 RUNX1 RUNX3 TAF3 TLE1 TLE4 | 9.17e-04 | 596 | 207 | 15 | GO:0005667 |
| Domain | ZnF_C2HC | FAM90A14 GFI1 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 9.78e-08 | 55 | 195 | 8 | SM00343 |
| Domain | Znf_CCHC | FAM90A14 GFI1 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 9.78e-08 | 55 | 195 | 8 | IPR001878 |
| Domain | SH2 | 9.12e-05 | 101 | 195 | 7 | PF00017 | |
| Domain | cwf21 | 1.08e-04 | 2 | 195 | 2 | PF08312 | |
| Domain | P66_CC | 1.08e-04 | 2 | 195 | 2 | IPR032346 | |
| Domain | Med13_N | 1.08e-04 | 2 | 195 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 1.08e-04 | 2 | 195 | 2 | IPR021643 | |
| Domain | F_actin_bind | 1.08e-04 | 2 | 195 | 2 | PF08919 | |
| Domain | F-actin_binding | 1.08e-04 | 2 | 195 | 2 | IPR015015 | |
| Domain | Med13_C | 1.08e-04 | 2 | 195 | 2 | PF06333 | |
| Domain | P66_CC | 1.08e-04 | 2 | 195 | 2 | PF16563 | |
| Domain | Mediator_Med13 | 1.08e-04 | 2 | 195 | 2 | IPR009401 | |
| Domain | FABD | 1.08e-04 | 2 | 195 | 2 | SM00808 | |
| Domain | Znf_piccolo | 1.08e-04 | 2 | 195 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.08e-04 | 2 | 195 | 2 | PF05715 | |
| Domain | mRNA_splic_Cwf21_dom | 1.08e-04 | 2 | 195 | 2 | IPR013170 | |
| Domain | SH2 | 1.56e-04 | 110 | 195 | 7 | SM00252 | |
| Domain | SH2 | 1.65e-04 | 111 | 195 | 7 | PS50001 | |
| Domain | SH2 | 1.75e-04 | 112 | 195 | 7 | IPR000980 | |
| Domain | - | 1.75e-04 | 112 | 195 | 7 | 3.30.505.10 | |
| Domain | Runt | 3.23e-04 | 3 | 195 | 2 | PF00853 | |
| Domain | RUNT | 3.23e-04 | 3 | 195 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 3.23e-04 | 3 | 195 | 2 | IPR016554 | |
| Domain | RunxI | 3.23e-04 | 3 | 195 | 2 | PF08504 | |
| Domain | Runt_dom | 3.23e-04 | 3 | 195 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 3.23e-04 | 3 | 195 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 3.23e-04 | 3 | 195 | 2 | IPR027384 | |
| Domain | - | 3.23e-04 | 3 | 195 | 2 | 4.10.770.10 | |
| Domain | FAM117 | 3.23e-04 | 3 | 195 | 2 | PF15388 | |
| Domain | AML1_Runt | 3.23e-04 | 3 | 195 | 2 | IPR000040 | |
| Domain | Glcci1/FAM117 | 3.23e-04 | 3 | 195 | 2 | IPR026642 | |
| Domain | PTPc_motif | 3.74e-04 | 59 | 195 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.74e-04 | 59 | 195 | 5 | IPR003595 | |
| Domain | - | 4.06e-04 | 92 | 195 | 6 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 6.01e-04 | 99 | 195 | 6 | IPR029021 | |
| Domain | Tensin_PTB | 6.42e-04 | 4 | 195 | 2 | IPR033929 | |
| Domain | Groucho_enhance | 1.06e-03 | 5 | 195 | 2 | IPR009146 | |
| Domain | TLE_N | 1.06e-03 | 5 | 195 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.06e-03 | 5 | 195 | 2 | IPR005617 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.58e-03 | 6 | 195 | 2 | IPR012346 | |
| Domain | - | 1.58e-03 | 6 | 195 | 2 | 2.60.40.720 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.87e-21 | 25 | 213 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.40e-17 | 23 | 213 | 10 | 18602769 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A SETX HIVEP2 ABL1 ABL2 MYCBP2 BCAS3 CLASP2 DENND2B GLCCI1 FSIP2 TJP2 KIF14 TNS3 WDR62 CDC42BPA SAMD4B DTL BAG3 CAMSAP3 FAM117B FSD1 RFX7 SPECC1 VIRMA CCDC88C MEGF8 SRRM2 MUSK | 1.13e-13 | 861 | 213 | 29 | 36931259 |
| Pubmed | KIF26A BCAS3 KMT2E CASZ1 ATXN7 NYNRIN MKI67 BSN CRAMP1 TNS3 WHRN CACNA1A DNAH3 UBR4 PERM1 SRRM2 | 1.47e-12 | 233 | 213 | 16 | 37704626 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP HIVEP2 ABL1 MYCBP2 KIF26A MFHAS1 BCAS3 APBB3 CUL9 CLASP2 ARHGEF11 CASZ1 PKD1 MTMR3 CRAMP1 PLXNA1 MED13 TRAF7 CDC42BPA DOCK9 UBR4 MED13L GTF2IRD1 RABL6 CCDC88C MEGF8 MTMR14 EHMT1 TNK2 ESPL1 RAI1 | 1.78e-12 | 1105 | 213 | 31 | 35748872 |
| Pubmed | DAB2IP MYCBP2 NHSL2 TNRC6B CLASP2 ARHGEF11 DCX RTN1 ZEB2 GATAD2B ATXN2 BSN MGA SHANK1 CACNA1A NYAP2 ANK3 UBR4 SH3GL2 CAMSAP3 SPECC1L PEX5L VIRMA CCDC88C ZSCAN18 EHMT1 TNS1 CNOT1 RAI1 | 1.79e-12 | 963 | 213 | 29 | 28671696 | |
| Pubmed | SMG1 BCL9L KLF12 GATAD2A NACA GON4L TNRC6B CUL9 MEF2A ZEB2 GATAD2B STAT5A BRD8 GSE1 ATXN2 ATXN7 MKI67 RPRD2 MGA REXO4 CDC42BPA RB1 UBR4 RFX7 RBM20 TAF3 TLE1 TLE4 ZSCAN18 EHMT1 LSM14A SRRM2 CNOT1 LRIF1 | 1.25e-11 | 1429 | 213 | 34 | 35140242 | |
| Pubmed | DAB2IP CDCA3 MYCBP2 ZNF174 PTPN22 CLASP2 PTPRC GSE1 ATXN2 MKI67 MTMR3 MLH1 KIF14 TNS3 PPP4R1 CDC42BPA ANK3 BAG3 CAMSAP3 CCDC77 CDCA8 RBM20 NCOA5 MTMR14 PPP4R2 CDC25A SRRM2 TNS1 CNOT1 | 1.41e-11 | 1049 | 213 | 29 | 27880917 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | AOC1 FAM90A14 FAM90A17 FAM90A19 RB1 FAM90A1 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 3.21e-11 | 164 | 213 | 13 | 22967998 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L DENND4A MYCBP2 PTPN22 CLASP2 GSE1 TJP2 KIF14 MYO18B CPLANE1 TNS3 ANK3 UBR4 BAG3 ATP10A SRRM2 | 9.87e-10 | 361 | 213 | 16 | 26167880 |
| Pubmed | SETX HIVEP2 ABL2 KIF26A NCKAP5 ARHGEF11 MAP3K4 CPLANE1 MGA SHANK1 CDC42BPA ANK3 BAG3 SPECC1L BHLHE40 USF3 TNK2 TNS1 | 1.50e-09 | 486 | 213 | 18 | 20936779 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 MYCBP2 GATAD2B BRD8 PTPRC GSE1 ATXN7 MKI67 TJP2 MED13 WDR62 SAMD4B BAG3 CAMSAP3 RUNX1 RFX7 GTF2IRD1 VIRMA TAF3 TLE4 ESPL1 SRRM2 | 2.95e-09 | 774 | 213 | 22 | 15302935 |
| Pubmed | DAB2IP DGKB GON4L TNRC6B CUL9 ZEB2 MAP3K4 GSE1 MTMR3 WHRN DOCK9 MED13L VIRMA MEGF8 TLE4 SRRM2 | 5.46e-09 | 407 | 213 | 16 | 12693553 | |
| Pubmed | NRIP1 MYCBP2 TNRC6B RBBP8NL ZEB2 GSE1 KIF14 MGA WDR62 UBR4 BAG3 CAMSAP3 RBM20 TLE1 TLE4 CNOT1 | 7.96e-09 | 418 | 213 | 16 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX GATAD2A ZNF174 ZEB2 CASZ1 GATAD2B KNOP1 FSIP2 MKI67 MLH1 MGA REXO4 RB1 CDCA8 TAF3 ZSCAN18 EHMT1 LRIF1 RAI1 | 8.28e-09 | 608 | 213 | 19 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 HIVEP2 MYCBP2 BCAS3 TNRC6B CLASP2 RBBP8NL DENND2B MEF2A CASZ1 ATXN2 ATXN7 RPRD2 CRAMP1 PRUNE2 CDC42BPA ANK3 FOLH1 SAMD4B CAMSAP3 FAM117B GTF2IRD1 ATP10A USF3 EHMT1 TNK2 LSM14A SYTL1 CNOT1 RAI1 | 1.08e-08 | 1489 | 213 | 30 | 28611215 |
| Pubmed | BCL9L MEF2A CASZ1 BRD8 GSE1 RPRD2 MGA MED13 U2SURP MED13L TLE1 TLE4 RAI1 | 1.32e-08 | 268 | 213 | 13 | 33640491 | |
| Pubmed | DAB2IP KLF12 SETX AOC1 CLASP2 DCX KNOP1 BRD8 PTPRC TJP2 CPLANE1 MGA TICRR POC1A ANK3 DOCK9 DTL TACC2 CCDC77 PPP4R2 TLE4 TMEM131 ESPL1 TNS1 CNOT1 | 1.53e-08 | 1084 | 213 | 25 | 11544199 | |
| Pubmed | DAB2IP PDE3A SETX GATAD2A GLCCI1 GATAD2B BRD8 MKI67 TJP2 RPRD2 SAMD4B DTL BAG3 CAMSAP3 TACC2 TMEM131 SRRM2 | 1.68e-08 | 503 | 213 | 17 | 16964243 | |
| Pubmed | DAB2IP ABL2 MYCBP2 BCAS3 RTN1 GLCCI1 BSN CACNA1A DOCK9 PCLO CAMSAP3 PEX5L SPECC1 SRRM2 | 3.67e-08 | 347 | 213 | 14 | 17114649 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L HIVEP2 ZEB2 GSE1 MKI67 MGA DTL RFX7 TAF3 TLE1 TLE4 EHMT1 LRIF1 RAI1 | 4.23e-08 | 351 | 213 | 14 | 38297188 |
| Pubmed | ABL1 ABL2 CUL9 NCKAP5 ARHGEF11 PKD1 MKI67 DLX4 MYO18B PPFIA4 GTF2IRD1 CD93 GUCY2D | 1.45e-07 | 329 | 213 | 13 | 17474147 | |
| Pubmed | DAB2IP BCL9L MYCBP2 BCAS3 NACA TNRC6B RTN1 GATAD2B TJP2 MAP7D2 BSN SHANK1 CACNA1A NYAP2 CDC42BPA ANK3 DOCK9 PCLO U2SURP UBR4 SH3GL2 CAMSAP3 TACC2 CNOT1 | 1.61e-07 | 1139 | 213 | 24 | 36417873 | |
| Pubmed | SMG1 NRIP1 GATAD2A CASZ1 GSE1 ATXN7 BSN FAT4 NYAP2 UBR4 MUC16 VIRMA RAD51AP2 MEGF8 EHMT1 CNOT1 RAI1 | 4.91e-07 | 638 | 213 | 17 | 31182584 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KLF12 PTPN22 KMT2E ATXN2 SLA2 BSN MGA PRUNE2 ANK3 UBR4 FSD1 SH3D21 USF3 TNK2 | 4.99e-07 | 430 | 213 | 14 | 35044719 |
| Pubmed | 9.02e-07 | 4 | 213 | 3 | 25869926 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.92e-07 | 167 | 213 | 9 | 20362541 | |
| Pubmed | SMG1 SETX KIF26A NACA RPRD2 BSN CRAMP1 MED13 NYAP2 CDC42BPA EHMT1 ROBO2 ESPL1 CNOT1 RAI1 | 1.10e-06 | 529 | 213 | 15 | 14621295 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NRIP1 GATAD2A GON4L ZEB2 CASZ1 GATAD2B MGA RB1 PCLO MSH4 FAM90A1 RBM20 TLE1 | 1.24e-06 | 398 | 213 | 13 | 35016035 |
| Pubmed | 1.30e-06 | 14 | 213 | 4 | 21085653 | ||
| Pubmed | SETX GATAD2A MYCBP2 ZNF174 PTPN22 MEF2A ZEB2 GFI1 GATAD2B GSE1 ATXN2 MKI67 U2SURP MED13L RUNX1 PPP4R2 EHMT1 LSM14A SRRM2 CNOT1 LRIF1 RAI1 | 1.35e-06 | 1103 | 213 | 22 | 34189442 | |
| Pubmed | C11orf98 BCL9L SETX NACA GON4L TNRC6B CLASP2 ARHGEF11 CASZ1 GATAD2B KNOP1 BRD8 ATXN2 ATXN7 MLH1 KIF14 MED13 REXO4 CDC42BPA SAMD4B CAMSAP3 SPECC1L SPECC1 VIRMA EHMT1 LSM14A | 1.85e-06 | 1497 | 213 | 26 | 31527615 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.22e-06 | 184 | 213 | 9 | 32908313 | |
| Pubmed | 2.24e-06 | 5 | 213 | 3 | 11804332 | ||
| Pubmed | 2.24e-06 | 5 | 213 | 3 | 31914386 | ||
| Pubmed | Spinocerebellar ataxias: microsatellite and allele frequency in unaffected and affected individuals. | 2.24e-06 | 5 | 213 | 3 | 20069235 | |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 2.30e-06 | 35 | 213 | 5 | 26091241 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | MYCBP2 KIF26A MKI67 KIF14 RPRD2 CAMSAP3 SPECC1L SPECC1 VIRMA NCOA5 TMEM131 SRRM2 | 2.68e-06 | 361 | 213 | 12 | 30344098 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRIP1 PTPN22 CLASP2 ARHGEF11 MAP3K4 STAT5A TJP2 ANK3 DOCK9 U2SURP CAMSAP3 RABL6 CNOT1 RAI1 | 2.72e-06 | 497 | 213 | 14 | 36774506 |
| Pubmed | SMG1 NRIP1 DENND4A MYCBP2 GON4L CLASP2 KMT2E GSE1 MYO18B MGA MED13 CDC42BPA DOCK9 MTMR14 | 2.72e-06 | 497 | 213 | 14 | 23414517 | |
| Pubmed | MYCBP2 NACA TNRC6B CLASP2 RTN1 GATAD2B TJP2 KIF14 RPRD2 MGA TNS3 WDR62 DTL TLE1 TMEM131 ESPL1 PDZRN3 | 3.21e-06 | 733 | 213 | 17 | 34672954 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | MYCBP2 TNRC6B AGBL5 GSE1 MAP7D2 DTL CAMSAP3 FAM117B GTF2IRD1 FAM222B LSM14A | 3.45e-06 | 307 | 213 | 11 | 37499664 |
| Pubmed | A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. | 3.50e-06 | 38 | 213 | 5 | 38346162 | |
| Pubmed | BCL9L DENND4A TNRC6B CLASP2 NYNRIN MTMR3 TJP2 KIF14 WDR62 SAMD4B CCDC77 CCDC88C CNOT1 | 4.31e-06 | 446 | 213 | 13 | 24255178 | |
| Pubmed | 4.47e-06 | 6 | 213 | 3 | 16389595 | ||
| Pubmed | Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. | 4.47e-06 | 6 | 213 | 3 | 9751710 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX GATAD2A BCAS3 CUL9 MEF2A ZEB2 CASZ1 GATAD2B BRD8 GSE1 MGA KIF27 RB1 UBR4 CBFA2T3 TLE1 TLE4 CDC25A | 6.42e-06 | 857 | 213 | 18 | 25609649 |
| Pubmed | CDCA3 SETX TNRC6B CLASP2 KNOP1 MKI67 TJP2 MGA FAT4 REXO4 CDC42BPA ANK3 PODXL MUC16 SPECC1L RABL6 EHMT1 | 6.90e-06 | 777 | 213 | 17 | 35844135 | |
| Pubmed | 7.54e-06 | 21 | 213 | 4 | 15514019 | ||
| Pubmed | 7.79e-06 | 7 | 213 | 3 | 16314515 | ||
| Pubmed | 1.13e-05 | 225 | 213 | 9 | 12168954 | ||
| Pubmed | 1.24e-05 | 8 | 213 | 3 | 22558218 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 1.24e-05 | 8 | 213 | 3 | 28296634 | |
| Pubmed | 1.24e-05 | 8 | 213 | 3 | 27879203 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.27e-05 | 125 | 213 | 7 | 32891193 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.64e-05 | 130 | 213 | 7 | 35545047 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 SETX CUL9 GSE1 KIF14 BSN PPP4R1 TRAF7 RB1 DTL TACC2 RBM20 PPP4R2 LRIF1 | 1.81e-05 | 588 | 213 | 14 | 38580884 |
| Pubmed | 1.85e-05 | 9 | 213 | 3 | 21144999 | ||
| Pubmed | GATAD2A TNRC6B CUL9 GATAD2B KNOP1 BRD8 GSE1 ATXN7 RTL9 MLH1 MGA WDR62 TRAF7 RB1 TAF3 ARSB EHMT1 SRRM2 PDZRN3 RAI1 | 1.97e-05 | 1116 | 213 | 20 | 31753913 | |
| Pubmed | 1.99e-05 | 134 | 213 | 7 | 24658140 | ||
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 2.00e-05 | 90 | 213 | 6 | 16273093 | |
| Pubmed | C11orf98 MYCBP2 CIART GON4L SLC35B2 PKD1 MLH1 KIF14 HCFC1R1 MED13 TICRR PGGHG PODXL FAM117B TACC2 SPECC1L SPECC1 SH3D21 NCOA5 SHF TNK2 | 2.07e-05 | 1215 | 213 | 21 | 15146197 | |
| Pubmed | 2.15e-05 | 27 | 213 | 4 | 19208226 | ||
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 2.19e-05 | 136 | 213 | 7 | 25402006 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABL2 TNRC6B ARHGEF11 TJP2 KIF14 MAP7D2 CPLANE1 MGA WDR62 SH3GL2 CAMSAP3 CCDC77 CCDC88C MTMR14 TMEM131 CNOT1 PDZRN3 | 2.28e-05 | 853 | 213 | 17 | 28718761 |
| Pubmed | The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study. | 2.63e-05 | 10 | 213 | 3 | 19259763 | |
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 2.63e-05 | 10 | 213 | 3 | 19235102 | |
| Pubmed | SMG1 DENND4A NHSL2 ZNF174 DACT2 ZEB2 KNOP1 ATXN7 MAP7D2 BSN MED13 COL20A1 PPFIA4 PCLO U2SURP UBR4 DTL CAMSAP3 CCDC77 SH3D21 ADAMTS12 LSM14A RAI1 | 2.91e-05 | 1442 | 213 | 23 | 35575683 | |
| Pubmed | 3.60e-05 | 11 | 213 | 3 | 24349473 | ||
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 3.60e-05 | 11 | 213 | 3 | 20351715 | |
| Pubmed | Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. | 3.73e-05 | 2 | 213 | 2 | 15987940 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 3.73e-05 | 2 | 213 | 2 | 23403927 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 3.73e-05 | 2 | 213 | 2 | 26793095 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 22665498 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 12220663 | ||
| Pubmed | The bivariate NRIP1/ZEB2 RNA marker permits non-invasive presymptomatic screening of pre-eclampsia. | 3.73e-05 | 2 | 213 | 2 | 33318568 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 3.73e-05 | 2 | 213 | 2 | 21935939 | |
| Pubmed | Expression patterns and prognostic value of RUNX genes in kidney cancer. | 3.73e-05 | 2 | 213 | 2 | 34294773 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 19403666 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 17686996 | ||
| Pubmed | Relative atrophy of the flocculus and ocular motor dysfunction in SCA2 and SCA6. | 3.73e-05 | 2 | 213 | 2 | 15826995 | |
| Pubmed | p600, a unique protein required for membrane morphogenesis and cell survival. | 3.73e-05 | 2 | 213 | 2 | 16214886 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 26883634 | ||
| Pubmed | Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus. | 3.73e-05 | 2 | 213 | 2 | 20181697 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 18649926 | ||
| Pubmed | Age-related changes in Ki-67 and DCX expression in the BALB/ c mouse (Mus Musculus) brain. | 3.73e-05 | 2 | 213 | 2 | 30472241 | |
| Pubmed | c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. | 3.73e-05 | 2 | 213 | 2 | 20150913 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 19710359 | ||
| Pubmed | Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases. | 3.73e-05 | 2 | 213 | 2 | 28555614 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 26053522 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 19805386 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 8242749 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 11731260 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 27321892 | ||
| Pubmed | Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity. | 3.73e-05 | 2 | 213 | 2 | 12626632 | |
| Pubmed | The Abl family kinases: mechanisms of regulation and signaling. | 3.73e-05 | 2 | 213 | 2 | 12374288 | |
| Pubmed | GFI1 is required for RUNX1/ETO positive acute myeloid leukemia. | 3.73e-05 | 2 | 213 | 2 | 29674496 | |
| Pubmed | Defective T cell development and function in the absence of Abelson kinases. | 3.73e-05 | 2 | 213 | 2 | 18025176 | |
| Pubmed | Abelson phosphorylation of CLASP2 modulates its association with microtubules and actin. | 3.73e-05 | 2 | 213 | 2 | 24520051 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 15034051 | ||
| Interaction | YWHAH interactions | DAB2IP NRIP1 DENND4A SETX HIVEP2 ABL1 ABL2 MYCBP2 NHSL2 BCAS3 CLASP2 DENND2B GLCCI1 MTMR3 TJP2 KIF14 TNS3 WDR62 TICRR CDC42BPA DOCK9 SAMD4B DTL BAG3 CAMSAP3 FAM117B FSD1 SPECC1L RFX7 SPECC1 VIRMA CCDC88C MEGF8 CDC25A SRRM2 | 7.85e-10 | 1102 | 199 | 35 | int:YWHAH |
| Interaction | HDAC1 interactions | NRIP1 GATAD2A MYCBP2 BCAS3 GON4L TNRC6B KMT2E MEF2A ZEB2 GFI1 CASZ1 GATAD2B STAT5A GSE1 MKI67 KIF14 MGA PPP4R1 CDC42BPA RB1 FOLH1 UBR4 BAG3 CAMSAP3 RUNX1 CBFA2T3 RUNX3 BHLHE40 VIRMA RBM20 TLE1 TLE4 EHMT1 RAI1 | 3.42e-09 | 1108 | 199 | 34 | int:HDAC1 |
| Interaction | TOP3B interactions | DAB2IP HIVEP2 ABL1 MYCBP2 KIF26A MFHAS1 BCAS3 APBB3 TNRC6B CUL9 CLASP2 ARHGEF11 CASZ1 ATXN2 PKD1 MTMR3 KIF14 CRAMP1 PLXNA1 MED13 TRAF7 CDC42BPA POC1A DOCK9 SAMD4B UBR4 MED13L GTF2IRD1 RABL6 CCDC88C MEGF8 MTMR14 EHMT1 TNK2 LSM14A ESPL1 CNOT1 RAI1 | 3.76e-08 | 1470 | 199 | 38 | int:TOP3B |
| Interaction | YWHAG interactions | DAB2IP DENND4A HIVEP2 ABL1 ABL2 MYCBP2 NHSL2 BCAS3 CLASP2 DENND2B GLCCI1 MTMR3 TJP2 KIF14 TNS3 WDR62 TICRR CDC42BPA DOCK9 SAMD4B DTL BAG3 CAMSAP3 FAM117B SPECC1L RFX7 SPECC1 VIRMA CCDC88C TNK2 CDC25A SRRM2 | 6.37e-07 | 1248 | 199 | 32 | int:YWHAG |
| Interaction | YWHAB interactions | DAB2IP DENND4A ABL1 ABL2 MYCBP2 CLASP2 DENND2B GLCCI1 MTMR3 TJP2 KIF14 TNS3 WDR62 TICRR CDC42BPA DOCK9 SAMD4B DTL BAG3 CAMSAP3 FAM117B RFX7 SPECC1 VIRMA CCDC88C CDC25A SRRM2 | 2.64e-06 | 1014 | 199 | 27 | int:YWHAB |
| Interaction | NUP43 interactions | BCL9L SETX GATAD2A GON4L TNRC6B KNOP1 FSIP2 BRD8 GSE1 MKI67 MGA REXO4 CDCA8 VIRMA CD93 TAF3 GUCY2D EHMT1 SRRM2 CNOT1 | 4.10e-06 | 625 | 199 | 20 | int:NUP43 |
| Interaction | YWHAQ interactions | DAB2IP NRIP1 PDE3A DENND4A HIVEP2 ABL1 ABL2 MYCBP2 CLASP2 DENND2B GLCCI1 TJP2 KIF14 TNS3 WDR62 TICRR CDC42BPA SAMD4B DTL BAG3 CAMSAP3 FAM117B SPECC1L RFX7 SPECC1 VIRMA CCDC88C CDC25A | 5.45e-06 | 1118 | 199 | 28 | int:YWHAQ |
| Interaction | AR interactions | BCL9L NRIP1 ABL1 ABL2 MYCBP2 MEF2A CASZ1 GATAD2B BRD8 GSE1 RPRD2 MGA MED13 CDC42BPA RB1 FOLH1 U2SURP MED13L RUNX1 VIRMA TLE1 TLE4 TNK2 CDC25A TNS1 RAI1 | 5.48e-06 | 992 | 199 | 26 | int:AR |
| Interaction | YWHAZ interactions | DAB2IP AANAT DENND4A HIVEP2 ABL1 ABL2 MYCBP2 CLASP2 DENND2B GLCCI1 MAP3K4 FSIP2 MTMR3 TJP2 KIF14 WDR62 TICRR CDC42BPA DOCK9 SAMD4B DTL BAG3 CAMSAP3 FAM117B TACC2 SPECC1 VIRMA CCDC88C TNK2 CDC25A TNS1 | 5.90e-06 | 1319 | 199 | 31 | int:YWHAZ |
| Interaction | RCOR1 interactions | KLF12 GATAD2A MYCBP2 ZNF174 TNRC6B ZEB2 GFI1 GSE1 MKI67 MGA WDR62 UBR4 BAG3 CAMSAP3 VIRMA RBM20 EHMT1 | 8.77e-06 | 494 | 199 | 17 | int:RCOR1 |
| Interaction | H3C3 interactions | SETX GATAD2A ZNF174 ZEB2 GATAD2B KNOP1 FSIP2 MKI67 MLH1 MGA REXO4 RB1 CDCA8 ZSCAN18 EHMT1 LRIF1 RAI1 | 9.00e-06 | 495 | 199 | 17 | int:H3C3 |
| Interaction | SRPK2 interactions | BCL9L ABL1 MYCBP2 PTPN22 CLASP2 KNOP1 GSE1 MKI67 TJP2 MYO18B CPLANE1 TNS3 REXO4 ANK3 U2SURP UBR4 BAG3 FAM90A1 VIRMA TLE4 SRRM2 | 9.08e-06 | 717 | 199 | 21 | int:SRPK2 |
| Interaction | HDAC2 interactions | NRIP1 GATAD2A MYCBP2 ZEB2 GFI1 CASZ1 GATAD2B GSE1 MKI67 KIF14 RPRD2 RB1 PODXL BAG3 RUNX1 CBFA2T3 RUNX3 VIRMA EHMT1 LSM14A ESPL1 SRRM2 RAI1 | 1.59e-05 | 865 | 199 | 23 | int:HDAC2 |
| Interaction | YWHAE interactions | DAB2IP DENND4A HIVEP2 ABL1 ABL2 MYCBP2 CLASP2 DCX DENND2B GLCCI1 MTMR3 TJP2 KIF14 MGA WDR62 TICRR CDC42BPA DOCK9 SAMD4B DTL BAG3 CAMSAP3 FAM117B TACC2 SPECC1 VIRMA CCDC88C CDC25A SRRM2 | 1.71e-05 | 1256 | 199 | 29 | int:YWHAE |
| Interaction | CEP135 interactions | TNRC6B GSE1 RTL9 TJP2 KIF14 CAMSAP3 CCDC77 NCOA5 CCDC88C CEP70 TMEM131 CNOT1 | 1.76e-05 | 272 | 199 | 12 | int:CEP135 |
| Interaction | SMG7 interactions | SMG1 TNRC6B GSE1 ATXN2 TJP2 RPRD2 SAMD4B RBM20 TLE1 TLE4 ZSCAN18 LSM14A CNOT1 | 1.82e-05 | 319 | 199 | 13 | int:SMG7 |
| Interaction | MYOD1 interactions | 2.40e-05 | 194 | 199 | 10 | int:MYOD1 | |
| Interaction | FMR1 interactions | SMG1 MYCBP2 TNRC6B ATXN2 MKI67 KIF14 MAP7D2 BSN UBR4 BAG3 TACC2 VIRMA CLEC14A TLE4 LSM14A TNS1 CNOT1 | 2.50e-05 | 536 | 199 | 17 | int:FMR1 |
| Interaction | TNIK interactions | MYCBP2 DCX ZEB2 GATAD2B GSE1 MGA SHANK1 CACNA1A ANK3 SH3GL2 PEX5L VIRMA ZSCAN18 EHMT1 | 2.73e-05 | 381 | 199 | 14 | int:TNIK |
| Interaction | LINC02910 interactions | 4.37e-05 | 95 | 199 | 7 | int:LINC02910 | |
| Interaction | KALRN interactions | 4.67e-05 | 96 | 199 | 7 | int:KALRN | |
| Interaction | TDRD3 interactions | SMG1 TNRC6B ATXN2 TJP2 POC1A SAMD4B CCDC77 CLEC14A LSM14A CNOT1 | 5.10e-05 | 212 | 199 | 10 | int:TDRD3 |
| Interaction | SFN interactions | DENND4A ABL1 ABL2 MYCBP2 CLASP2 DENND2B TJP2 KIF14 TNS3 WDR62 CDC42BPA DTL CAMSAP3 FAM117B SPECC1 VIRMA CCDC88C CDC25A SRRM2 | 5.92e-05 | 692 | 199 | 19 | int:SFN |
| Interaction | CLK1 interactions | DENND4A MFHAS1 CUL9 PTPN22 TJP2 KIF14 DOCK9 BAG3 ATP10A SRRM2 | 6.69e-05 | 219 | 199 | 10 | int:CLK1 |
| Interaction | ALG13 interactions | 8.83e-05 | 183 | 199 | 9 | int:ALG13 | |
| Interaction | KLF3 interactions | 9.35e-05 | 228 | 199 | 10 | int:KLF3 | |
| Interaction | TRIM36 interactions | 9.39e-05 | 144 | 199 | 8 | int:TRIM36 | |
| Interaction | FAM90A26 interactions | 9.70e-05 | 2 | 199 | 2 | int:FAM90A26 | |
| Interaction | TLE3 interactions | BCL9L HIVEP2 BRD8 GSE1 PPP4R1 ANK3 RUNX1 VIRMA RBM20 TLE1 TLE4 ZSCAN18 SRRM2 | 9.82e-05 | 376 | 199 | 13 | int:TLE3 |
| Interaction | MAPRE3 interactions | FILIP1 NCKAP5 CLASP2 KIF14 MAP7D2 CAMSAP3 TACC2 SPECC1L SPECC1 TMEM131 | 1.01e-04 | 230 | 199 | 10 | int:MAPRE3 |
| Interaction | SORBS2 interactions | 1.18e-04 | 111 | 199 | 7 | int:SORBS2 | |
| Interaction | DCTN1 interactions | MYCBP2 NACA CLASP2 TJP2 KIF14 MAP7D2 WDR62 BAG3 CAMSAP3 SPECC1L SPECC1 VIRMA CCDC88C PPP4R2 ESPL1 | 1.31e-04 | 497 | 199 | 15 | int:DCTN1 |
| Interaction | MATN2 interactions | 1.32e-04 | 113 | 199 | 7 | int:MATN2 | |
| Interaction | KDM1A interactions | NRIP1 MYCBP2 TNRC6B RBBP8NL ZEB2 GFI1 GSE1 KIF14 MGA WDR62 RB1 UBR4 BAG3 CAMSAP3 CBFA2T3 VIRMA RBM20 TLE4 CEP70 EHMT1 ZBED1 CNOT1 | 1.62e-04 | 941 | 199 | 22 | int:KDM1A |
| Interaction | CPEB4 interactions | 1.64e-04 | 156 | 199 | 8 | int:CPEB4 | |
| Interaction | NELL2 interactions | 1.74e-04 | 53 | 199 | 5 | int:NELL2 | |
| Interaction | MIB1 interactions | FILIP1 TNRC6B PTPN22 MAP3K4 PER3 KIF14 MGA FSD1 CCDC77 VIRMA CNOT1 | 1.77e-04 | 295 | 199 | 11 | int:MIB1 |
| Interaction | ZBTB46 interactions | 1.81e-04 | 29 | 199 | 4 | int:ZBTB46 | |
| Interaction | MAPRE1 interactions | CLASP2 IGSF10 KIF14 MAP7D2 WDR62 BAG3 CAMSAP3 TACC2 SPECC1L CCDC77 SPECC1 LSM14A TMEM131 SRRM2 CNOT1 | 1.89e-04 | 514 | 199 | 15 | int:MAPRE1 |
| Interaction | CDH19 interactions | 2.07e-04 | 30 | 199 | 4 | int:CDH19 | |
| Interaction | CD247 interactions | 2.08e-04 | 55 | 199 | 5 | int:CD247 | |
| Interaction | SORBS1 interactions | 2.23e-04 | 123 | 199 | 7 | int:SORBS1 | |
| Interaction | SP7 interactions | 2.29e-04 | 304 | 199 | 11 | int:SP7 | |
| Cytoband | 8p23.1 | FAM90A14 MFHAS1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.03e-11 | 154 | 214 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 MFHAS1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.32e-09 | 234 | 214 | 12 | chr8p23 |
| Cytoband | 16p12.3 | 5.37e-04 | 34 | 214 | 3 | 16p12.3 | |
| Cytoband | 3p26 | 5.94e-04 | 8 | 214 | 2 | 3p26 | |
| Cytoband | 2p24.2 | 9.50e-04 | 10 | 214 | 2 | 2p24.2 | |
| Cytoband | 16p13.3 | 1.05e-03 | 244 | 214 | 6 | 16p13.3 | |
| Cytoband | 13q22 | 1.16e-03 | 11 | 214 | 2 | 13q22 | |
| GeneFamily | SH2 domain containing | 6.64e-07 | 101 | 130 | 8 | 741 | |
| GeneFamily | Protein phosphatase 4 regulatory subunits | 1.53e-04 | 3 | 130 | 2 | 698 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.05e-04 | 4 | 130 | 2 | 1244 | |
| GeneFamily | WD repeat domain containing | 6.20e-04 | 262 | 130 | 8 | 362 | |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 7.55e-04 | 6 | 130 | 2 | 411 | |
| GeneFamily | PDZ domain containing | 8.10e-04 | 152 | 130 | 6 | 1220 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.40e-03 | 8 | 130 | 2 | 837 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.40e-03 | 46 | 130 | 3 | 622 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.07e-03 | 15 | 130 | 2 | 26 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.07e-03 | 15 | 130 | 2 | 82 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 5.07e-03 | 15 | 130 | 2 | 903 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 SETX HIVEP2 MYCBP2 CLASP2 DENND2B MEF2A ZEB2 MAP3K4 GSE1 ATXN2 MTMR3 TJP2 KIF14 MED13 CDC42BPA RB1 PODXL DOCK9 U2SURP SPECC1L MED13L RUNX1 BHLHE40 TLE1 TLE4 TMEM131 | 6.53e-10 | 856 | 203 | 27 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 HIVEP2 MYCBP2 CLASP2 ATXN2 TJP2 KIF14 MED13 CDC42BPA RB1 U2SURP SPECC1L MED13L RUNX1 BHLHE40 TLE1 TLE4 TMEM131 | 2.74e-08 | 466 | 203 | 18 | M13522 |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | DAB2IP NRIP1 KMT2E MEF2A GFI1 CBFA2T3 GTF2IRD1 ATP10A TMEM131 RAI1 | 5.47e-07 | 161 | 203 | 10 | M7728 |
| Coexpression | BENPORATH_CYCLING_GENES | CDCA3 MYCBP2 BRD8 GSE1 MKI67 KIF14 CPLANE1 WDR62 POC1A SH3GL2 DTL BAG3 RUNX1 CDCA8 NCOA5 CEP70 CDC25A ESPL1 LRIF1 | 7.88e-07 | 648 | 203 | 19 | M8156 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | DENND4A CHN2 DCX RTN1 CASZ1 PRUNE2 CACNA1A PCLO TACC2 CBFA2T3 SPECC1 ESPL1 PDZRN3 | 8.03e-07 | 304 | 203 | 13 | M45711 |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 9.79e-07 | 68 | 203 | 7 | M41108 | |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN | 1.65e-06 | 47 | 203 | 6 | M40911 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 2.52e-06 | 111 | 203 | 8 | M7357 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 3.57e-06 | 198 | 203 | 10 | M8041 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 3.73e-06 | 199 | 203 | 10 | M9885 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | SMG1 BCL9L KLF12 MYCBP2 MFHAS1 TNRC6B MKI67 TJP2 CBFA2T3 TMEM131 | 3.73e-06 | 199 | 203 | 10 | M9124 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 KLF12 DENND4A SETX HIVEP2 MYCBP2 TNRC6B PTPN22 KMT2E GLCCI1 ZEB2 GFI1 GATAD2B STAT5A PTPRC ATXN7 SLA2 MED13 PGGHG DOCK9 U2SURP UBR4 RFX7 RUNX3 BHLHE40 CCDC88C TNK2 LSM14A CNOT1 | 4.67e-06 | 1492 | 203 | 29 | M40023 |
| Coexpression | GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN | 6.87e-06 | 127 | 203 | 8 | M2915 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | CHN2 DCX RTN1 CASZ1 PRUNE2 CACNA1A PCLO TACC2 CBFA2T3 ROBO2 PDZRN3 | 8.46e-06 | 268 | 203 | 11 | M45696 |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 9.99e-06 | 176 | 203 | 9 | M9137 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYCBP2 KMT2E CHN2 DCX ADARB2 RTN1 CASZ1 FSIP2 GSE1 MAP7D2 BSN PLXNA1 CACNA1A ANK3 PPFIA4 PCLO FAM117B MED13L RFX7 PEX5L TNK2 ROBO2 RAI1 | 1.72e-05 | 1106 | 203 | 23 | M39071 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NRIP1 HIVEP2 ABL1 BRD8 GSE1 MKI67 KIF14 DOCK9 MED13L TLE4 LSM14A | 2.42e-05 | 300 | 203 | 11 | M8702 |
| Coexpression | GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN | 2.66e-05 | 199 | 203 | 9 | M6205 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DAB2IP SMG1 BCL9L DENND4A ABL1 DENND2B MEF2A CASZ1 KNOP1 GSE1 TJP2 HCFC1R1 CXCL6 TRAF7 DTL RUNX1 GTF2IRD1 SPECC1 TLE1 | 3.32e-05 | 843 | 203 | 19 | M2356 |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 6.14e-05 | 127 | 203 | 7 | M40952 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL | 9.01e-05 | 233 | 203 | 9 | M45712 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | SMG1 NRIP1 KLF12 GON4L ANK3 DOCK9 FAM117B RFX7 VIRMA USF3 MTMR14 TLE4 EHMT1 | 9.02e-05 | 474 | 203 | 13 | M40991 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 9.48e-05 | 183 | 203 | 8 | M2993 | |
| Coexpression | ZHONG_PFC_C1_OPC | 1.06e-04 | 238 | 203 | 9 | M39096 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.10e-04 | 97 | 203 | 6 | M14698 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 1.42e-04 | 194 | 203 | 8 | M8864 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.53e-04 | 250 | 203 | 9 | M11318 | |
| Coexpression | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP | 1.56e-04 | 14 | 203 | 3 | M17421 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.62e-04 | 66 | 203 | 5 | M10845 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP | 1.63e-04 | 198 | 203 | 8 | M4636 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.63e-04 | 198 | 203 | 8 | M6123 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN | 1.63e-04 | 198 | 203 | 8 | M6731 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 1.69e-04 | 199 | 203 | 8 | M4635 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 1.69e-04 | 199 | 203 | 8 | M6198 | |
| Coexpression | GSE27786_BCELL_VS_CD8_TCELL_UP | 1.75e-04 | 200 | 203 | 8 | M4801 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 1.75e-04 | 200 | 203 | 8 | M4894 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP | 1.75e-04 | 200 | 203 | 8 | M7147 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 1.75e-04 | 200 | 203 | 8 | M6044 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN | 1.75e-04 | 200 | 203 | 8 | M5294 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP | 1.75e-04 | 200 | 203 | 8 | M4323 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | SETX NACA ZEB2 GSE1 MLH1 MYO18B TNS3 PODXL MED13L RBM20 TLE1 PDZRN3 | 1.81e-04 | 441 | 203 | 12 | M172 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.89e-04 | 152 | 203 | 7 | M39243 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 1.89e-04 | 107 | 203 | 6 | M39165 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 1.99e-04 | 108 | 203 | 6 | MM1334 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.99e-04 | 69 | 203 | 5 | MM621 | |
| Coexpression | FISCHER_DREAM_TARGETS | CDCA3 GATAD2A KNOP1 BRD8 MKI67 KIF14 WDR62 TICRR POC1A DTL RUNX1 CCDC77 CDCA8 BHLHE40 RFWD3 NCOA5 CDC25A ESPL1 CNOT1 | 2.05e-04 | 969 | 203 | 19 | M149 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KLF12 HIVEP2 ABL2 MFHAS1 GON4L MEF2A ZEB2 PER3 GSE1 PKD1 MTMR3 BAG3 MED13L GTF2IRD1 BHLHE40 TLE1 LRIF1 | 2.42e-04 | 822 | 203 | 17 | M6782 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 2.42e-04 | 389 | 203 | 11 | M39073 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | CHN2 DCX ADARB2 RTN1 CASZ1 GSE1 MAP7D2 BSN USH2A ANK3 FAM117B ROBO2 | 2.93e-04 | 465 | 203 | 12 | M39066 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | SMG1 FILIP1 NRIP1 KLF12 SETX GATAD2A MYCBP2 KIF26A BCAS3 TNRC6B CLASP2 AGBL5 DCX RTN1 ZEB2 GATAD2B STAT5A CPLANE1 MED13 FAT4 ANK3 RUNX1 PEX5L CD93 | 5.37e-07 | 818 | 195 | 24 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 KLF12 SETX GATAD2A MYCBP2 BCAS3 TNRC6B CLASP2 ZEB2 GATAD2B CPLANE1 MED13 ANK3 PEX5L CD93 | 2.94e-06 | 385 | 195 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | DAB2IP KLF12 DENND4A PTPN22 CHN2 DENND2B ZEB2 PTPRC SLA2 HS3ST3B1 RUNX3 BHLHE40 ARSB TNK2 | 1.38e-05 | 385 | 195 | 14 | GSM538285_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | KLF12 DENND4A DGKB NCKAP5 AGBL5 KMT2E DCX RTN1 GLCCI1 SSC5D GSE1 MTMR3 SHANK1 WHRN CACNA1A CDC42BPA PCLO RUNX3 SPECC1 TLE4 | 1.38e-05 | 730 | 195 | 20 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | KLF12 DENND4A DGKB NCKAP5 AGBL5 KMT2E DCX RTN1 GLCCI1 SSC5D GSE1 MAP7D2 SHANK1 WHRN CACNA1A PCLO RUNX3 SPECC1 CCDC88C TLE4 | 1.92e-05 | 747 | 195 | 20 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | NK cells, NK.Sp, NK1.1+, Spleen, avg-3 | DAB2IP KLF12 DENND4A PTPN22 CHN2 DENND2B ZEB2 SLA2 HS3ST3B1 RUNX3 BHLHE40 CCDC88C ARSB TNK2 | 2.69e-05 | 409 | 195 | 14 | GSM538315_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | CDCA3 NRIP1 MKI67 KIF14 SLA2 TICRR DTL RUNX3 GTF2IRD1 CDCA8 CD93 TNK2 SYTL1 CDC25A | 2.92e-05 | 412 | 195 | 14 | GSM605793_500 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | CDCA3 DENND4A PTPN22 MKI67 KIF14 SLA2 TICRR DTL RUNX3 CDCA8 BHLHE40 ATP10A ARSB | 2.94e-05 | 359 | 195 | 13 | GSM605773_500 |
| CoexpressionAtlas | NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | DAB2IP BCL9L KLF12 PTPN22 CHN2 DENND2B ZEB2 GSE1 SLA2 HS3ST3B1 RUNX3 BHLHE40 ARSB TNK2 | 3.00e-05 | 413 | 195 | 14 | GSM538303_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 KLF12 PDE3A SETX MYCBP2 KIF26A CLASP2 DCX GATAD2B CPLANE1 MED13 ANK3 | 3.34e-05 | 312 | 195 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | CDCA3 NRIP1 CHN2 MKI67 KIF14 SLA2 TICRR DTL GTF2IRD1 CDCA8 CD93 TNK2 CDC25A ESPL1 | 3.79e-05 | 422 | 195 | 14 | GSM476658_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | CDCA3 NRIP1 NYNRIN MKI67 KIF14 SLA2 TICRR DTL RUNX3 GTF2IRD1 CDCA8 CD93 TNK2 SYTL1 | 3.89e-05 | 423 | 195 | 14 | GSM476655_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 7.23e-05 | 149 | 195 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3 | DAB2IP KLF12 DENND4A PTPN22 CHN2 DENND2B ZEB2 SLA2 HS3ST3B1 RUNX3 BHLHE40 ARSB TNK2 | 9.31e-05 | 402 | 195 | 13 | GSM538297_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DGKB NCKAP5 DCX RTN1 KNOP1 GLRA1 MKI67 LYPLA1 MAP7D2 ALOX15 WDR62 CACNA1A RB1 PCLO U2SURP CAMSAP3 GTF2IRD1 RFWD3 CCDC88C USF3 CEP70 LRIF1 | 1.17e-04 | 989 | 195 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SMG1 NRIP1 KLF12 ABL2 NHSL2 KMT2E ZEB2 ATXN2 CPLANE1 MGA RUNX1 ROBO2 TNS1 | 1.22e-04 | 413 | 195 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | CDCA3 NYNRIN SLA2 TICRR POC1A DTL RUNX1 CBFA2T3 CDCA8 CD93 SYTL1 ESPL1 TNS1 | 1.28e-04 | 415 | 195 | 13 | GSM791134_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | SMG1 FILIP1 KLF12 TNRC6B DCX RTN1 ZEB2 GATAD2B STAT5A CPLANE1 MED13 ANK3 PEX5L | 1.31e-04 | 416 | 195 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.40e-04 | 209 | 195 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | CDCA3 MKI67 KIF14 SLA2 TICRR DTL RUNX1 CDCA8 CD93 SYTL1 CDC25A ESPL1 TNS1 | 1.44e-04 | 420 | 195 | 13 | GSM791141_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 DENND4A DGKB NCKAP5 AGBL5 KMT2E DCX RTN1 GLCCI1 SSC5D MAP7D2 SHANK1 WHRN CACNA1A PCLO RUNX3 CCDC88C TLE4 | 1.49e-04 | 732 | 195 | 18 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | CDCA3 MEF2A GFI1 GSE1 MKI67 KIF14 SLA2 WHRN GTF2IRD1 ATP10A TNK2 RAI1 | 1.57e-04 | 367 | 195 | 12 | GSM399391_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 1.94e-04 | 91 | 195 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 1.94e-04 | 91 | 195 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | NRIP1 CHN2 DCX RTN1 TJP2 MAP7D2 ALOX15 ANK3 RB1 PCLO CAMSAP3 RUNX1 PEX5L CCDC88C | 2.04e-04 | 495 | 195 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 2.96e-04 | 231 | 195 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 3.52e-04 | 66 | 195 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 DENND4A DGKB NCKAP5 KMT2E DCX RTN1 GLCCI1 SSC5D GSE1 SHANK1 WHRN CACNA1A PCLO RUNX3 SPECC1 TLE4 | 3.77e-04 | 722 | 195 | 17 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | FILIP1 KLF12 PDE3A SETX DCX RTN1 GATAD2B STAT5A CPLANE1 MED13 FAT4 ANK3 | 4.10e-04 | 408 | 195 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | CDCA3 CHN2 MKI67 KIF14 SLA2 TICRR DTL GTF2IRD1 CDCA8 CD93 CDC25A ESPL1 | 4.67e-04 | 414 | 195 | 12 | GSM476660_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 5.27e-04 | 72 | 195 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | CDCA3 MKI67 KIF14 WDR62 TICRR POC1A PCLO DTL CDCA8 CD93 ESPL1 | 2.10e-09 | 199 | 203 | 11 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-09 | 167 | 203 | 10 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CDCA3 MKI67 KIF14 WDR62 TICRR POC1A CCDC77 CDCA8 RFWD3 ESPL1 | 1.22e-08 | 182 | 203 | 10 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-08 | 187 | 203 | 10 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-08 | 187 | 203 | 10 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | FILIP1 NCKAP5 CASZ1 MYO18B PRUNE2 ANK3 TACC2 GTF2IRD1 RBM20 ROBO2 | 1.66e-08 | 188 | 203 | 10 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CDCA3 MKI67 KIF14 WDR62 TICRR POC1A CDCA8 RFWD3 CDC25A ESPL1 | 1.75e-08 | 189 | 203 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDCA3 ANKRD36C MKI67 KIF14 WDR62 TICRR DOCK9 DTL CDCA8 RFWD3 | 1.84e-08 | 190 | 203 | 10 | 31de1727822e9818652946dfb962daee77ffad68 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | FILIP1 PDE3A NCKAP5 CHN2 CASZ1 MYO18B ANK3 TACC2 RBM20 PDZRN3 | 1.84e-08 | 190 | 203 | 10 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.93e-08 | 191 | 203 | 10 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.13e-08 | 193 | 203 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-08 | 193 | 203 | 10 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-08 | 194 | 203 | 10 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-08 | 194 | 203 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-08 | 194 | 203 | 10 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-08 | 194 | 203 | 10 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.24e-08 | 194 | 203 | 10 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.24e-08 | 194 | 203 | 10 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.35e-08 | 195 | 203 | 10 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | FILIP1 PDE3A NCKAP5 CASZ1 MYO18B ANK3 TACC2 GTF2IRD1 RBM20 PDZRN3 | 2.35e-08 | 195 | 203 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | CDCA3 ZEB2 IGSF10 MKI67 KIF14 CDC42BPA POC1A DTL CBFA2T3 CDCA8 | 2.35e-08 | 195 | 203 | 10 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.35e-08 | 195 | 203 | 10 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.35e-08 | 195 | 203 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.47e-08 | 196 | 203 | 10 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 2.47e-08 | 196 | 203 | 10 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CDCA3 RBBP8NL MKI67 KIF14 TICRR POC1A DTL CDCA8 RAD51AP2 CDC25A | 2.59e-08 | 197 | 203 | 10 | 25bbe270d0897b9b1bd00d205f66efd1def81b99 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.59e-08 | 197 | 203 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 2.59e-08 | 197 | 203 | 10 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.72e-08 | 198 | 203 | 10 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-08 | 198 | 203 | 10 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.85e-08 | 199 | 203 | 10 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.85e-08 | 199 | 203 | 10 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.85e-08 | 199 | 203 | 10 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | DENND2B IGSF10 MKI67 KIF14 TICRR DNAH3 DTL FAM90A1 CDC25A ESPL1 | 2.85e-08 | 199 | 203 | 10 | e222b90caf45904d8f763574e7b6aac13333df92 |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-08 | 149 | 203 | 9 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-08 | 200 | 203 | 10 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 2.99e-08 | 200 | 203 | 10 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 2.99e-08 | 200 | 203 | 10 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.99e-08 | 200 | 203 | 10 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 2.99e-08 | 200 | 203 | 10 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.99e-08 | 200 | 203 | 10 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-08 | 200 | 203 | 10 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.07e-08 | 165 | 203 | 9 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-07 | 175 | 203 | 9 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 180 | 203 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.56e-07 | 181 | 203 | 9 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 1.56e-07 | 181 | 203 | 9 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 1.56e-07 | 181 | 203 | 9 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.63e-07 | 182 | 203 | 9 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.71e-07 | 183 | 203 | 9 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-07 | 184 | 203 | 9 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 185 | 203 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-07 | 186 | 203 | 9 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | SMG1 DENND4A TNRC6B ANKRD36C ZEB2 PTPRC MED13 MED13L TMEM131 | 2.15e-07 | 188 | 203 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-07 | 188 | 203 | 9 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.25e-07 | 189 | 203 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-07 | 190 | 203 | 9 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-07 | 190 | 203 | 9 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-07 | 190 | 203 | 9 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.46e-07 | 191 | 203 | 9 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-07 | 192 | 203 | 9 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | background-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.69e-07 | 193 | 203 | 9 | f8d6eff1e04926f85d265ec39fe66897fe29574d | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-07 | 193 | 203 | 9 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.81e-07 | 194 | 203 | 9 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.81e-07 | 194 | 203 | 9 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-07 | 194 | 203 | 9 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-07 | 194 | 203 | 9 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 2.93e-07 | 195 | 203 | 9 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.93e-07 | 195 | 203 | 9 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.93e-07 | 195 | 203 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.93e-07 | 195 | 203 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 2.93e-07 | 195 | 203 | 9 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.06e-07 | 196 | 203 | 9 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.06e-07 | 196 | 203 | 9 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 3.06e-07 | 196 | 203 | 9 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-07 | 197 | 203 | 9 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-07 | 197 | 203 | 9 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 3.20e-07 | 197 | 203 | 9 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-07 | 197 | 203 | 9 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-07 | 197 | 203 | 9 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 3.20e-07 | 197 | 203 | 9 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 3.20e-07 | 197 | 203 | 9 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 3.20e-07 | 197 | 203 | 9 | aca6cbff7391ff550061bb7daa67fc5f6585806a | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 3.33e-07 | 198 | 203 | 9 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.33e-07 | 198 | 203 | 9 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.33e-07 | 198 | 203 | 9 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-07 | 198 | 203 | 9 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 3.33e-07 | 198 | 203 | 9 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.33e-07 | 198 | 203 | 9 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-07 | 198 | 203 | 9 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-07 | 198 | 203 | 9 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 198 | 203 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.48e-07 | 199 | 203 | 9 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.48e-07 | 199 | 203 | 9 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-07 | 199 | 203 | 9 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.48e-07 | 199 | 203 | 9 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 3.48e-07 | 199 | 203 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 199 | 203 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 3.48e-07 | 199 | 203 | 9 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 199 | 203 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | SETX WDR62 WHRN CACNA1A CDC42BPA PPFIA4 DOCK9 RUNX1 RUNX3 SLC9A2 TNK2 TNS1 | 1.97e-07 | 198 | 200 | 12 | 6622_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | NRIP1 HIVEP2 CLASP2 KIF14 TNS3 DOCK9 DTL MED13L GTF2IRD1 TLE4 PDZRN3 | 4.21e-07 | 174 | 200 | 11 | 7530_DN |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A | DENND4A MFHAS1 PTPN22 PLXNA1 MED13 U2SURP GTF2IRD1 CDCA8 TLE1 TLE4 SRRM2 | 1.37e-06 | 196 | 200 | 11 | 2019_DN |
| Drug | Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A | ABL2 GON4L DENND2B MEF2A PER3 MTMR3 WDR62 RB1 RUNX1 BHLHE40 EHMT1 | 1.59e-06 | 199 | 200 | 11 | 6074_DN |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.01e-05 | 197 | 200 | 10 | 6759_UP | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | ARHGEF11 ATXN7 HCFC1R1 CPLANE1 WHRN DOCK9 RUNX1 RUNX3 TNS1 CNOT1 | 1.06e-05 | 198 | 200 | 10 | 6668_DN |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.06e-05 | 198 | 200 | 10 | 5858_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.13e-05 | 171 | 200 | 9 | 7535_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NRIP1 RPRD2 TNS3 TACC2 MED13L CBFA2T3 GTF2IRD1 BHLHE40 SRRM2 | 2.23e-05 | 172 | 200 | 9 | 1072_DN |
| Disease | cortical surface area measurement | FILIP1 PDE3A MYCBP2 MFHAS1 TNRC6B CUL9 NCKAP5 AGBL5 GATAD2B ATXN2 GLRA1 PKD1 MLH1 HS3ST3B1 CACNA1A TICRR NYAP2 ANK3 PODXL DOCK9 PERM1 FAM117B MED13L CCDC88C TLE4 ROBO2 TNS1 PDZRN3 | 8.71e-08 | 1345 | 196 | 28 | EFO_0010736 |
| Disease | red blood cell density measurement | KLF12 DENND4A BCAS3 TNRC6B RBBP8NL ARHGEF11 DENND2B ZEB2 CASZ1 PTPRC ATXN2 TJP2 TNS3 NYAP2 PODXL RUNX1 RFX7 SPECC1 TAF3 FAM222B MUSK | 4.73e-07 | 880 | 196 | 21 | EFO_0007978 |
| Disease | Spinocerebellar Ataxia Type 2 | 2.92e-06 | 34 | 196 | 5 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.92e-06 | 34 | 196 | 5 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.92e-06 | 34 | 196 | 5 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.92e-06 | 34 | 196 | 5 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.92e-06 | 34 | 196 | 5 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.92e-06 | 34 | 196 | 5 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.39e-06 | 35 | 196 | 5 | C0752122 | |
| Disease | retinal vasculature measurement | CDCA3 PDE3A DGKB NCKAP5 ADARB2 DENND2B GLCCI1 MUC17 ATXN2 TJP2 CDC42BPA PERM1 MED13L TNS1 | 1.04e-05 | 517 | 196 | 14 | EFO_0010554 |
| Disease | intellectual disability (implicated_via_orthology) | 1.09e-05 | 75 | 196 | 6 | DOID:1059 (implicated_via_orthology) | |
| Disease | platelet crit | NRIP1 GATAD2A KIF26A NHSL2 BCAS3 ARHGEF11 DENND2B PTPRC GSE1 ATXN2 RPRD2 DNAH3 NYAP2 U2SURP DTL RUNX1 SH3D21 SLC9A2 TLE4 | 2.15e-05 | 952 | 196 | 19 | EFO_0007985 |
| Disease | reticulocyte count | AANAT DENND4A GATAD2A BCAS3 TNRC6B DENND2B PTPRC ATXN2 PKD1 MTMR3 BSN TNS3 NYAP2 U2SURP FAM117B RUNX3 SPECC1 LSM14A TMEM131 TNS1 | 2.35e-05 | 1045 | 196 | 20 | EFO_0007986 |
| Disease | reticulocyte measurement | AANAT DENND4A GATAD2A TNRC6B DENND2B ZEB2 PTPRC ATXN2 MTMR3 BSN TNS3 NYAP2 U2SURP CBFA2T3 RUNX3 SPECC1 SH3D21 LSM14A TMEM131 TNS1 | 2.62e-05 | 1053 | 196 | 20 | EFO_0010700 |
| Disease | neuroimaging measurement | GATAD2A TNRC6B NCKAP5 ARHGEF11 GLCCI1 GATAD2B ATXN2 PKD1 CDC42BPA ANK3 PODXL DOCK9 TACC2 CCDC88C TLE4 ROBO2 TNS1 PDZRN3 MUSK RAI1 | 3.24e-05 | 1069 | 196 | 20 | EFO_0004346 |
| Disease | diastolic blood pressure, systolic blood pressure | AOC1 GATAD2A TNRC6B RBBP8NL KMT2E DENND2B CASZ1 ATXN2 ALOX15 WDR62 POC1A ANK3 CBFA2T3 FAM222B GUCY2D | 4.57e-05 | 670 | 196 | 15 | EFO_0006335, EFO_0006336 |
| Disease | coronary artery disease | DAB2IP HIVEP2 CIART BCAS3 ADARB2 DENND2B ZEB2 IGSF10 ATXN2 RPRD2 CFAP161 BSN TNS3 FAT4 NYAP2 DOCK9 SPECC1L NT5C1B CDC25A TNS1 RAI1 | 4.98e-05 | 1194 | 196 | 21 | EFO_0001645 |
| Disease | total blood protein measurement | AOC1 ATXN2 NYNRIN PKD1 DNAH3 NYAP2 RUNX1 CBFA2T3 RUNX3 TLE4 TMEM131 MUSK | 5.10e-05 | 449 | 196 | 12 | EFO_0004536 |
| Disease | alkaline phosphatase measurement | KLF12 AOC1 MFHAS1 PTPN22 DENND2B ATXN2 NYNRIN PKD1 WHRN TRAF7 REXO4 PGGHG U2SURP RUNX1 BHLHE40 TIRAP CNOT1 MUSK RAI1 | 5.10e-05 | 1015 | 196 | 19 | EFO_0004533 |
| Disease | mean corpuscular hemoglobin concentration | AANAT DENND4A GATAD2A GON4L TNRC6B ZEB2 PTPRC ATXN2 MTMR3 MED13 TNS3 TICRR NYAP2 RUNX1 SPECC1 SLC9A2 FAM222B LSM14A LRIF1 MUSK | 5.13e-05 | 1105 | 196 | 20 | EFO_0004528 |
| Disease | serum IgA measurement | 5.16e-05 | 31 | 196 | 4 | EFO_0004912 | |
| Disease | Drugs used in diabetes use measurement | 5.61e-05 | 255 | 196 | 9 | EFO_0009924 | |
| Disease | eosinophil measurement | 8.68e-05 | 108 | 196 | 6 | EFO_0803540 | |
| Disease | monocyte percentage of leukocytes | NRIP1 DENND4A ARHGEF11 GLCCI1 GFI1 PTPRC ATXN2 CXCL6 NYAP2 CDC42BPA FAM117B MED13L RUNX1 ARSB MUSK | 1.20e-04 | 731 | 196 | 15 | EFO_0007989 |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.24e-04 | 15 | 196 | 3 | C2930967 | |
| Disease | myocardial infarction | DAB2IP BCAS3 DGKB DENND2B ZEB2 ATXN2 CFAP161 NYAP2 DOCK9 TNS1 | 1.26e-04 | 350 | 196 | 10 | EFO_0000612 |
| Disease | cortical thickness | GATAD2A MYCBP2 TNRC6B CUL9 NCKAP5 GATAD2B ATXN2 PKD1 MTMR3 NYAP2 DOCK9 TACC2 SPECC1 SHF ROBO2 LSM14A TMEM131 TNS1 MUSK | 1.69e-04 | 1113 | 196 | 19 | EFO_0004840 |
| Disease | QRS duration | 1.82e-04 | 298 | 196 | 9 | EFO_0005055 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.83e-04 | 17 | 196 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | monocyte count | NRIP1 DENND4A BCAS3 GON4L PTPN22 DENND2B GFI1 CASZ1 PTPRC GSE1 ATXN2 PKD1 TNS3 LILRB3 NYAP2 CDC42BPA U2SURP MED13L RUNX1 PPP4R2 RAI1 | 2.01e-04 | 1320 | 196 | 21 | EFO_0005091 |
| Disease | atrial fibrillation | FILIP1 KLF12 NACA DGKB CASZ1 MYO18B CRAMP1 PPFIA4 PERM1 RBM20 | 2.02e-04 | 371 | 196 | 10 | EFO_0000275 |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 2.61e-04 | 4 | 196 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | DAB2IP CASZ1 PTPRC MLH1 RPRD2 MGA RB1 FOLH1 PODXL RUNX1 TIRAP ROBO2 ZBED1 | 2.62e-04 | 616 | 196 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | DAB2IP CASZ1 PTPRC MLH1 RPRD2 MGA RB1 FOLH1 PODXL RUNX1 TIRAP ROBO2 ZBED1 | 2.62e-04 | 616 | 196 | 13 | C0376358 |
| Disease | left ventricular structural measurement | 3.08e-04 | 88 | 196 | 5 | EFO_0008205 | |
| Disease | neutrophil count | DENND4A HIVEP2 MYCBP2 PTPN22 KMT2E DENND2B GLCCI1 CASZ1 PTPRC ATXN2 ATXN7 PKD1 RPRD2 CXCL6 TNS3 PRUNE2 CACNA1A CDC42BPA CBFA2T3 RUNX3 MUSK | 3.70e-04 | 1382 | 196 | 21 | EFO_0004833 |
| Disease | stomach cancer (is_marker_for) | 3.85e-04 | 142 | 196 | 6 | DOID:10534 (is_marker_for) | |
| Disease | pulse pressure measurement | NRIP1 PDE3A GATAD2A MFHAS1 TNRC6B ANKRD36C CASZ1 ATXN7 PKD1 TNS3 TRAF7 NYAP2 FOLH1 PODXL MED13L OMD CCDC77 MEGF8 CDC25A CNOT1 MUSK | 4.07e-04 | 1392 | 196 | 21 | EFO_0005763 |
| Disease | stroke | 4.15e-04 | 144 | 196 | 6 | EFO_0000712 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.30e-04 | 335 | 196 | 9 | EFO_0009931 | |
| Disease | Sleep Disorders, Circadian Rhythm | 4.33e-04 | 5 | 196 | 2 | C0877792 | |
| Disease | Delayed Sleep Phase Syndrome | 4.33e-04 | 5 | 196 | 2 | C0393770 | |
| Disease | Usher Syndrome, Type II | 4.33e-04 | 5 | 196 | 2 | C1568249 | |
| Disease | Shift-Work Sleep Disorder | 4.33e-04 | 5 | 196 | 2 | C0751760 | |
| Disease | Non-24 Hour Sleep-Wake Disorder | 4.33e-04 | 5 | 196 | 2 | C0751759 | |
| Disease | Advanced Sleep Phase Syndrome | 4.33e-04 | 5 | 196 | 2 | C0751758 | |
| Disease | Nonorganic Sleep Wake Cycle Disorders | 4.33e-04 | 5 | 196 | 2 | C0494410 | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.61e-04 | 54 | 196 | 4 | EFO_0004792 | |
| Disease | peak expiratory flow | PDE3A CIART KMT2E PKD1 ANK3 FOLH1 PODXL DOCK9 RUNX1 NT5C1B PDZRN3 | 5.34e-04 | 498 | 196 | 11 | EFO_0009718 |
| Disease | myeloid white cell count | NRIP1 KLF12 PDE3A ABL1 PTPN22 KMT2E DENND2B GLCCI1 PTPRC ATXN2 PKD1 CXCL6 TNS3 PRUNE2 CDC42BPA MUSK | 5.57e-04 | 937 | 196 | 16 | EFO_0007988 |
| Disease | platelet component distribution width | NRIP1 HIVEP2 BRD8 PTPRC GSE1 ATXN2 NYNRIN MLH1 PRUNE2 NYAP2 DOCK9 U2SURP C4orf54 MUSK | 5.58e-04 | 755 | 196 | 14 | EFO_0007984 |
| Disease | Vitiligo | 5.81e-04 | 101 | 196 | 5 | EFO_0004208 | |
| Disease | blood cobalt measurement | 5.81e-04 | 101 | 196 | 5 | EFO_0007577 | |
| Disease | Abnormality of refraction | CDCA3 SMG1 NRIP1 KLF12 PDE3A CIART BCAS3 MTMR3 TJP2 ANK3 PCLO RUNX1 PPP4R2 | 6.03e-04 | 673 | 196 | 13 | HP_0000539 |
| Disease | Paroxysmal atrial fibrillation | 6.33e-04 | 156 | 196 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 6.33e-04 | 156 | 196 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.33e-04 | 156 | 196 | 6 | C2585653 | |
| Disease | amino acid measurement | SETX DGKB ADARB2 MAP3K4 PER3 CXCL6 ALOX15 FAT4 NYAP2 FOLH1 TACC2 GTF2IRD1 RAD51AP2 | 6.45e-04 | 678 | 196 | 13 | EFO_0005134 |
| Disease | migraine disorder | 6.78e-04 | 357 | 196 | 9 | MONDO_0005277 | |
| Disease | Atrial Fibrillation | 7.23e-04 | 160 | 196 | 6 | C0004238 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 8.28e-04 | 63 | 196 | 4 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | arachidonate 15-lipoxygenase B measurement | 9.02e-04 | 7 | 196 | 2 | EFO_0801391 | |
| Disease | Myeloid Leukemia, Chronic | 9.29e-04 | 29 | 196 | 3 | C0023473 | |
| Disease | QT interval | KLF12 PDE3A AOC1 CASZ1 CFAP161 CDC42BPA DTL CNOT1 PDZRN3 MUSK RAI1 | 9.44e-04 | 534 | 196 | 11 | EFO_0004682 |
| Disease | Diuretic use measurement | 9.61e-04 | 169 | 196 | 6 | EFO_0009928 | |
| Disease | Carcinoma, Granular Cell | 1.09e-03 | 116 | 196 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.09e-03 | 116 | 196 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.09e-03 | 116 | 196 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.09e-03 | 116 | 196 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.09e-03 | 116 | 196 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.09e-03 | 116 | 196 | 5 | C0001418 | |
| Disease | fatty acid measurement, linoleic acid measurement | 1.10e-03 | 68 | 196 | 4 | EFO_0005110, EFO_0006807 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.14e-03 | 239 | 196 | 7 | EFO_0010934 | |
| Disease | Myopia | 1.15e-03 | 385 | 196 | 9 | HP_0000545 | |
| Disease | Nonorganic psychosis | 1.17e-03 | 69 | 196 | 4 | C0349204 | |
| Disease | helping behavior measurement | 1.20e-03 | 8 | 196 | 2 | EFO_0008538 | |
| Disease | waist circumference, sexual dimorphism | 1.20e-03 | 8 | 196 | 2 | EFO_0004342, EFO_0005951 | |
| Disease | body mass index, coronary artery disease | 1.20e-03 | 8 | 196 | 2 | EFO_0001645, EFO_0004340 | |
| Disease | LDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 1.20e-03 | 8 | 196 | 2 | EFO_0007804, GO_1901557, GO_1903491 | |
| Disease | JT interval | 1.40e-03 | 248 | 196 | 7 | EFO_0007885 | |
| Disease | pentachlorophenol measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 1.44e-03 | 73 | 196 | 4 | EFO_0022059 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPEPDPGSRRSTKMQ | 196 | Q96P26 | |
| MKGSSGPTSPTPRTR | 801 | Q8NDL9 | |
| SDTSPMKRSASVLGP | 2116 | O00555 | |
| NAPTPPKRSSSFREM | 661 | P42684 | |
| PTVMVRSPIDSASPG | 181 | Q9H0E9 | |
| MSTKPANELPLTPRE | 766 | Q8IZF6 | |
| PAPPASIMERISASK | 856 | Q86V15 | |
| GTSRKPSDPAPKVMD | 186 | O14503 | |
| MLRERSPSPPTIQSK | 821 | Q14687 | |
| TAKDQGRPPRSSTMS | 1391 | Q6V0I7 | |
| PITSAPLKMLAPSGS | 526 | Q9NPY3 | |
| FTPKMGRRSIESPSL | 671 | O15085 | |
| PSGPKSRPVESIMTL | 276 | A7E2U8 | |
| RGMADSLESTPLPSP | 31 | Q9BR77 | |
| RVRPLPAASSGMKSS | 21 | Q5M775 | |
| PASLPRVPAMESAKT | 926 | Q69YQ0 | |
| RSVPMPLSNISVPKS | 276 | Q86VQ1 | |
| SSMLDLPKPPTEDTR | 276 | Q6P656 | |
| TPPASETKIMSPRKA | 516 | Q9NZJ0 | |
| TAMAEPSPGTLPRKA | 16 | P19801 | |
| RSLMESPFPAPGKTI | 831 | P78524 | |
| RSDPVSMPGSSRPVS | 796 | Q9H6U6 | |
| KRPTSRAPSPSGLMS | 1066 | Q9P1Y5 | |
| MTSLPCPLPGRDASK | 1 | Q92988 | |
| MSLPSSRAARVPGPS | 1 | P80162 | |
| ASGPMPVHTTSKRPR | 146 | A6NDY2 | |
| PAPMSSAPGEAVLRS | 1391 | O60312 | |
| TSRPRMLTTPTGPES | 1026 | P58397 | |
| TATVRPMPQAALDPK | 906 | Q07912 | |
| PRSPTLGIARTPMKT | 66 | Q99618 | |
| SSSPNSPLPMFRRTK | 726 | Q7Z401 | |
| SEGLPTPTKMTPRSR | 816 | P06400 | |
| PTPRMAELRKPTSSL | 6 | Q09MP3 | |
| TDSPSTPGKDQRSMI | 1131 | Q7Z5J4 | |
| ERPEGSPTLFKRMSS | 1261 | Q7Z5J4 | |
| MSSPKPAEERARQPS | 1046 | Q5T481 | |
| CKDLSSPTPSEPRME | 906 | Q9UPQ7 | |
| EKRSSTRPPAEMEPG | 531 | Q3YEC7 | |
| SPQKSEPLLPSASMD | 266 | Q6PCD5 | |
| RLSTRTPSPGDTPSM | 681 | Q9NS39 | |
| PPSGTSSKMSLDLPE | 541 | Q9Y2R2 | |
| ASGPMPVHTTSKRPR | 146 | A6NKC0 | |
| DPSSKAAMRRKDSPP | 561 | Q5JPF3 | |
| PAGKPSLQTSSARMP | 201 | Q86YP4 | |
| RRSLPGSLSEKSPSM | 51 | Q5VWQ8 | |
| ASGPMPVHTTSKRPR | 146 | A8MXZ1 | |
| MSRISLEPGTSLPPN | 4206 | Q8WXI7 | |
| SPPLLEKTRPSFSLM | 7961 | Q8WXI7 | |
| TKVPRPPATLASSMG | 311 | Q8NBT0 | |
| PATALRTPTLPETMS | 301 | O00592 | |
| ASRKTADMPLTPNPV | 71 | Q15058 | |
| KRNPASPSKSSPMTA | 6 | Q8NDB6 | |
| RAPPATPLASGKEMA | 91 | Q9Y662 | |
| SPALRSSKMPAVGTE | 826 | Q71F56 | |
| PLSTIDPSGTRSKNM | 336 | Q5T3J3 | |
| PTEPPMNKRLSSSTV | 176 | Q96T17 | |
| RPPSPSASPASEKSM | 91 | Q99684 | |
| SVMGIRLPAPSKPSE | 1836 | Q8IWI9 | |
| KAEGESSPPMARSTP | 761 | Q9Y4C4 | |
| SSPPMARSTPSQELL | 766 | Q9Y4C4 | |
| MLPPSVAEALKTGTP | 856 | Q02846 | |
| RMGSSPLEVPKPRSV | 526 | Q8NCE2 | |
| ASGPMPVHTTSKRPR | 146 | Q86YD7 | |
| NSPARGTPSPKRMPS | 316 | Q9BTV5 | |
| EMVSLTSPSAPPTSR | 891 | O75335 | |
| SSEGPPRMSPKAQRH | 616 | Q99700 | |
| SPSPEFSGMPRISKL | 501 | Q04609 | |
| PKPSSLSMAHSRVRP | 3481 | Q9UPA5 | |
| MVKPTPGLTPRFDSR | 181 | Q53HL2 | |
| PTVKMAAPTSEGRPL | 1731 | Q9P219 | |
| SEPTKRPDSETMPSC | 3221 | Q5CZC0 | |
| ASGPMPVHTTSKRPR | 146 | A8MWA6 | |
| ASGPMPVHTTSKRPR | 146 | P0C7W9 | |
| PSRQDSRKVHTSPPM | 596 | Q86VH2 | |
| QRSMSDPKPLSPTAD | 3676 | Q9Y6V0 | |
| IPAIPKSEMPTNGRS | 591 | P56645 | |
| PTASTLSMGLPPSRT | 1021 | P56645 | |
| SSPDSLRSRTPMITP | 1631 | Q9UIW2 | |
| SLGLPISPFMDRSAP | 981 | Q14432 | |
| GSPGLTRRMSKSPVD | 436 | Q8IYB4 | |
| KERLMRSSTDSLPGP | 371 | Q9HCD5 | |
| RKMPDSDAPPNVTVS | 231 | Q8WU58 | |
| TRPPPIEASSGKMLL | 106 | Q7Z7M0 | |
| TMGKSSRRPPTPTPE | 251 | Q13670 | |
| MDPSFATPPRIKSDD | 906 | Q8IZD2 | |
| MRLPPPTTKDATLET | 561 | P16050 | |
| MVEKRASPATSPKPS | 246 | P48552 | |
| PGHSKPSRSMESSPR | 226 | Q1ED39 | |
| PRKAVGTPMAASTPR | 886 | Q9ULI4 | |
| RSSPQLDPLRKSPTM | 181 | Q8ND56 | |
| VKHSSPRREMASPPS | 546 | O75022 | |
| MKPTSGPEEARRPAS | 1 | Q9UHC3 | |
| MDTPTSTRRRPKTPL | 2111 | P46013 | |
| RVSSPLPSPSAMTDA | 331 | Q8WXI9 | |
| IQMSPPKLPGSSSSE | 686 | Q32M88 | |
| ASGPMPVHTTSKRPR | 146 | P0DV74 | |
| SIKSEPISPPRDRMT | 401 | Q02078 | |
| SPSPVSMGRSLTPLS | 436 | Q9P242 | |
| AMPDSPAEVKTQPRS | 61 | O75081 | |
| ASGPMPVHTTSKRPR | 146 | P0DV73 | |
| PSGLSSVPSSPMSRK | 656 | O15265 | |
| ASGPMPVHTTSKRPR | 146 | P0DV76 | |
| ASGPMPVHTTSKRPR | 146 | A6NJQ4 | |
| SPGATLPESRAPDMS | 196 | Q8NC74 | |
| FGPTLMRPPEDSTLT | 431 | P52757 | |
| KRTSSMDSPGGPLPL | 436 | O95704 | |
| VLSKSMEAPSPPLRA | 321 | Q14674 | |
| TAVMLPKTSPALPRD | 1231 | Q6WRI0 | |
| ISPSRMLDKSPSPAS | 461 | Q5SW24 | |
| MSQPPLLPASAETRK | 1 | Q9BZ29 | |
| PKPQDSSQPSDRLMT | 6 | Q8NHQ1 | |
| LKPPNMFPSTSRASI | 2366 | Q9H799 | |
| LPSSGNRSSSEPMRK | 146 | Q8TD57 | |
| VKTSLTFPGSRPMSP | 191 | Q8TD57 | |
| LPTSDSPGMVELKAP | 321 | I3L273 | |
| RGTTESMPSPPLANS | 16 | F2Z3M2 | |
| KAPSPSQLSMTELPG | 646 | Q9P218 | |
| RGTSTVMPSASLLPP | 566 | Q6P1L5 | |
| MTPPGKVVTVSSRSP | 766 | Q96RY5 | |
| KSPGPMRRSKSPADS | 296 | O43602 | |
| SSMDPEVRLSSPPGK | 1416 | Q3T8J9 | |
| RSPTGSPSRLKSPSM | 986 | Q86UU0 | |
| MNKGAITPPRTTSPA | 111 | Q9Y6T7 | |
| APTPPKRSSSFREMD | 611 | P00519 | |
| RSSITMTPPASPKSN | 1636 | Q12955 | |
| LPRALMRSTTKTSGP | 306 | P01854 | |
| MRSTTKTSGPRAAPE | 311 | P01854 | |
| MSTPLPAIVPAARKA | 6 | O75608 | |
| PRNSMAPAKDDSSLP | 406 | P15848 | |
| MDPRGLSPRQSKSDS | 226 | Q9Y4X4 | |
| ASSPLRGAVPMSTKR | 31 | Q9NWW0 | |
| SGIAPRTEPMPTTRT | 901 | Q8IWT3 | |
| LSRPMPEPKATGAQD | 286 | Q9UHL9 | |
| SPLRGMPETTQPDKQ | 136 | O95817 | |
| PRGSELSPMVAEPSS | 1701 | D6RIA3 | |
| ASGPMPVHTTSKRPR | 146 | A8MXJ8 | |
| VMKNTGVSPASRPSP | 466 | Q5VT52 | |
| MSKALQDSAPDRPSP | 991 | Q9H9B1 | |
| PRMTESSGLVSTPVP | 436 | Q5SV97 | |
| PSPQSSPDLSKMTHR | 351 | Q6UX07 | |
| ASGPMPVHTTSKRPR | 146 | P0C7X0 | |
| PLNRPKVSLSAPMTT | 176 | Q9NY27 | |
| EESPPGSTKRRKSMS | 281 | P30304 | |
| SGKDRLPQTMEPSPS | 871 | Q13615 | |
| MSRSKVAGSPSPTPA | 3346 | P98161 | |
| EGMEPLPSRSSRGSK | 4156 | P98161 | |
| TQVPSAAPKLPTSRM | 561 | Q9P2P1 | |
| SNRLESMPPGLPSSL | 221 | Q99983 | |
| TPSEGSTPLTRMPVS | 1036 | Q685J3 | |
| TSTPSERTTPLAGMP | 2036 | Q685J3 | |
| EGSTPLRSMPVSTKP | 2571 | Q685J3 | |
| LIIPTPEGFSTRSMP | 1166 | Q9Y6R4 | |
| SVPSGSKMDRRAPVP | 131 | Q9GZR2 | |
| RRFTPPSTALSPGKM | 11 | Q01196 | |
| PSTALSPGKMSEALP | 16 | Q01196 | |
| MRVTPSTPSPRGSLS | 206 | Q13761 | |
| PPVRALDSGAMSTPL | 401 | Q8NET4 | |
| ATASGKMSTPLRRAP | 491 | Q8NET4 | |
| ETPMLPRKPEEDSSS | 546 | Q16799 | |
| PGPDPSLDRMLSSSS | 226 | Q8IYJ3 | |
| SPAMVGSPIRSPKTV | 291 | Q5VWG9 | |
| PLVKDRTSPSAPSGM | 4521 | O75445 | |
| SASSPEMKDGLPRTP | 1421 | Q9UQ35 | |
| GSSPGMKDIPRTPSR | 1461 | Q9UQ35 | |
| TAISLGTARPPPSMS | 2186 | Q9UQ35 | |
| SERAPSPSSRMGQAP | 2421 | Q9UQ35 | |
| KRIPPTPMNSLVESS | 606 | Q8WUY3 | |
| GPVPSSPNITMATRK | 491 | Q8TF05 | |
| MSTQSTHPLKPEAPR | 1 | Q16613 | |
| APSVKRTPMPDKTAT | 231 | A4FU49 | |
| MGSLPSRRKSLPSPS | 1 | Q9H6Q3 | |
| SSQRPTPTRIPMSKG | 1151 | Q7Z7B0 | |
| APSAPMLESLPSVGR | 1326 | O14513 | |
| ALTSPTLAMPPRSSI | 896 | Q5HYW2 | |
| ASGPMPVHTSSKRPR | 146 | A8MX19 | |
| AEAARSAPKPMSPSD | 26 | P23415 | |
| ASGPMPVHTTSKRPR | 146 | A6NNJ1 | |
| ASGPMPVHTTSKRPR | 146 | P0C7W8 | |
| SVTPPPRSAILTSMK | 3216 | Q96Q15 | |
| ASGPMPVHTTSKRPR | 146 | D6RGX4 | |
| SPAPRSTLSGAAMEP | 26 | Q9BVL4 | |
| EKPMAEDPVRPSSSV | 1166 | Q7Z333 | |
| MPLTEPLRGRSTSPK | 2886 | O75592 | |
| MLRPEISSTSPSAPA | 1 | O15457 | |
| KLGREDLQPPSSMPS | 601 | Q9P202 | |
| RDPAMSSVTLTPPTS | 316 | Q9UHV7 | |
| MPTTKHSRAQSPPDL | 646 | A1L4H1 | |
| SMDPLSTEDFKPPRS | 1401 | A1L4H1 | |
| SPIGPKSTMLRADAS | 901 | Q68CZ2 | |
| SEMSEKRGPTSSNPR | 456 | P40692 | |
| SITKSRPEPGRSMSA | 1616 | Q5VT25 | |
| SAKRQPMPSPSEGSL | 1656 | Q5VT25 | |
| ASGPMPVHTTSKRPR | 146 | P0C7V4 | |
| RLPPPTISLRSKSMT | 776 | Q9Y566 | |
| PMDSLDSRLSPPAGL | 771 | P42229 | |
| PSDSDMPSRTRPKSP | 36 | O15042 | |
| SPPSLPTLARKMTIG | 351 | Q8N365 | |
| HESPSSQPRKESMGP | 426 | Q86T13 | |
| GSIRPPDSLMTPKLR | 81 | Q6X4T0 | |
| TQSSMGSPLTRPTPR | 886 | O75122 | |
| MEVEAPSKPARTSEP | 86 | E9PRG8 | |
| VMPKGRPPSASSLDA | 691 | A5YKK6 | |
| SAKPLSMEPSSPLGE | 296 | Q7M4L6 | |
| KSSTPTPRSDMPTPG | 316 | Q04724 | |
| PSRLSRMGATPTPFK | 446 | Q9UDY2 | |
| SMPRASRSLSKPEPT | 1606 | Q7Z2Z1 | |
| PTPKLAGTEAPRMRS | 201 | Q15697 | |
| LLNAPRAMGTSSSPP | 36 | Q9UBY0 | |
| RDMPSTPPTPHSREK | 741 | Q9UBY0 | |
| SPLKRSMSLIPTSPQ | 231 | Q5PRF9 | |
| PGVDPLASSLRTPMA | 351 | Q04727 | |
| SMFLLSSGPEPRSSP | 251 | Q8TB61 | |
| PTRKMLTSRAPPTTL | 166 | Q8WTU2 | |
| QPKPRMSLEFPTGDS | 256 | Q99962 | |
| EMPSSGTPPLLNKSE | 416 | Q9BSK1 | |
| LPSKIPLPTAMTSGS | 1501 | Q92545 | |
| SPTPALPEKRRMSVG | 1381 | Q9HBL0 | |
| PSNLPTPDVTTGTRM | 16 | Q6Q0C0 | |
| QGLSDPSPMSDPVRT | 601 | Q9HCK4 | |
| QPPRTAGDSSPMSIS | 346 | Q68DE3 | |
| ESPVKSSPVRMSESP | 2556 | O95359 | |
| TSPSPMSSSDGKVLP | 281 | Q2KHR2 | |
| ESRPSMGRKLSSPTT | 2356 | Q8IUG5 | |
| SSPTTPRDMLLSPTL | 2366 | Q8IUG5 | |
| MLKTPSKDSLDPDPR | 811 | O43379 | |
| MASSTSLPAPGSRPK | 1 | P58753 | |
| MLPLEKAFASPRSSP | 1 | Q8TBC5 | |
| PSDSPSTPKTMLSRL | 106 | P0C1S8 | |
| KLMRTSTPPPASVIN | 531 | O96006 | |
| SLLPRSPVKPMDSIT | 726 | O60315 | |
| PSSREPFLPSKEMLS | 1531 | P31629 | |
| PFLPSKEMLSGSRAP | 1536 | P31629 | |
| PSTPSSPRLLMKQST | 2296 | P31629 | |
| LPSSPRSNTPMGDKD | 2716 | Q5T4S7 | |
| SPTGLTTAKMPSVPL | 31 | P08575 | |
| KSFPTMARITGPPER | 651 | Q69YN4 | |
| REPNLPTPMTSKSAS | 921 | Q9UPQ9 | |
| ASGPMPVHTTSKRPR | 146 | P0DV75 | |
| PMIAPTLKGTPSSSA | 121 | E9PAV3 | |
| SDLSMRAQVSSPGPP | 681 | O15146 |